The author asserts that proper labeling of medicinal basidiomycete products is an issue that cannot be ignored. He says that proper labeling is more important than ever for manufacturers to know what they are selling. He also discussed the statement issued by the U.S. Food and Drug Administration (FDA) on the mushroom mycelium, the mushroom primordia, and the life cycle of a basidiomycete.